We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Open-Label Trial of Sulforaphane in Premutation Carriers With FXTAS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT05233579
Recruitment Status : Recruiting
First Posted : February 10, 2022
Last Update Posted : February 10, 2022
Information provided by (Responsible Party):
University of California, Davis